Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Northwest Gastroenterologists S.C.
mi
from
Arlington Heights, IL
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Northwest Gastroenterologists S.C.
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Covenant Clinic
mi
from
Waterloo, IA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Covenant Clinic
mi
from
Waterloo, IA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Cotton O'Neil Digestive Health Center
mi
from
Topeka, KA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Cotton O'Neil Digestive Health Center
mi
from
Topeka, KA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
University of Louisville
mi
from
Louisville, KY
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Sinai Medical Office Building
mi
from
Baltimore, MD
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Sinai Medical Office Building
mi
from
Baltimore, MD
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Philip J. Beam Medical Center
mi
from
Hollywood, MD
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Philip J. Beam Medical Center
mi
from
Hollywood, MD
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Research Institute of Michigan, LLC
mi
from
Chesterfield, MI
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Research Institute of Michigan, LLC
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Center for Digestive & Liver Diseases Inc.
mi
from
Mexico, MO
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Center for Digestive & Liver Diseases Inc.
mi
from
Mexico, MO
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
St Louis Center For Clinical Research
mi
from
Saint Louis, MO
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
St Louis Center For Clinical Research
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Shore Health Group
mi
from
Ocean City, NJ
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Shore Health Group
mi
from
Ocean City, NJ
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Simon Lichtiger, M.D.
mi
from
New York, NY
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Simon Lichtiger, M.D.
mi
from
New York, NY
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
VA Medical Center, Northport
mi
from
Northport, NY
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
VA Medical Center, Northport
mi
from
Northport, NY
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
VA Medical Center
mi
from
Syracuse, NY
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
VA Medical Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Upstate Gastroenterology Associates, PC
mi
from
Troy, NY
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Upstate Gastroenterology Associates, PC
mi
from
Troy, NY
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
LeBauer Research Associates
mi
from
Greensboro, NC
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
LeBauer Research Associates
mi
from
Greensboro, NC
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Bethany Medical Center
mi
from
High Point, NC
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Bethany Medical Center
mi
from
High Point, NC
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Boice-Willis Clinic
mi
from
Rocky Mount, NC
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Boice-Willis Clinic
mi
from
Rocky Mount, NC
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Consultants for Clinical Research Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Avamar Center for Endoscopy
mi
from
Warren, OH
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Avamar Center for Endoscopy
mi
from
Warren, OH
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Oklahoma Gastroenterology Associates
mi
from
Tulsa, OK
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Oklahoma Gastroenterology Associates
mi
from
Tulsa, OK
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Charleston Gastroenterology Specialists, LLC
mi
from
Charleston, SC
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Charleston Gastroenterology Specialists, LLC
mi
from
Charleston, SC
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Hillcrest Clinical Research, LLC
mi
from
Simpsonville, SC
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Hillcrest Clinical Research, LLC
mi
from
Simpsonville, SC
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Medical Research Institute
mi
from
Nashville, TN
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Medical Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Nationsmed Clinical Research
mi
from
Houston, TX
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Nationsmed Clinical Research
mi
from
Houston, TX
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Clinical Trial Network
mi
from
Houston, TX
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Clinical Trial Network
mi
from
Houston, TX
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Houston Digestive Disease Clinic
mi
from
Houston, TX
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Houston Digestive Disease Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Gastroenterology Associates of Tidewater
mi
from
Chesapeake, VA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Gastroenterology Associates of Tidewater
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
New River Research Institute
mi
from
Christiansburg, VA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
New River Research Institute
mi
from
Christiansburg, VA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Seattle Gastroenterology Associates
mi
from
Seattle, WA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Seattle Gastroenterology Associates
mi
from
Seattle, WA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Eastern Washington Clinical Research Center
mi
from
Spokane, WA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Eastern Washington Clinical Research Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Spokane Digestive Disease Center
mi
from
Spokane, WA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Spokane Digestive Disease Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Digestive Disease Research Center
mi
from
Tacoma, WA
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Digestive Disease Research Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated:  12/11/2017
Center for Advanced Research
mi
from
Milwaukee, WI
Long-Term Safety and Tolerability of Mesalamine Pellets in Patients With Ulcerative Colitis in Remission
A Multicenter, Open-Label, Treatment Extension Trial to Evalaute the Long-Term Safety and Tolerability of Mesalamine Pellet Formulation
Status: Enrolling
Updated: 12/11/2017
Center for Advanced Research
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Prospective, Double-blind, Randomized, Placebo-controlled Study.
Status: Enrolling
Updated:  12/14/2017
University of Louisville Hospital
mi
from
Louisville, KY
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.
Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Prospective, Double-blind, Randomized, Placebo-controlled Study.
Status: Enrolling
Updated: 12/14/2017
University of Louisville Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Atlanta Gastroenterology Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
The University of Chicago Hospitals
mi
from
Chicago, IL
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
The University of Chicago Hospitals
mi
from
Chicago, IL
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Metropolitan Gastroenterology Group Practice/Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Metropolitan Gastroenterology Group Practice/Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Maryland Digestive Diseases Research
mi
from
Laurel, MD
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Maryland Digestive Diseases Research
mi
from
Laurel, MD
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Capitol Gastroenterology Consultants
mi
from
Silver Spring, MD
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Capitol Gastroenterology Consultants
mi
from
Silver Spring, MD
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Massachusetts General Hospital
mi
from
Boston, MA
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Minnesota Gastroenterology, P.A.
mi
from
Plymouth, MN
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
University Hospitals of Cleveland
mi
from
Cleveland, OH
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Avamar Center for Endoscopy
mi
from
Warren, OH
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Avamar Center for Endoscopy
mi
from
Warren, OH
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
University of Pennsylvania - Presbyterian Medical Center
mi
from
Philadelphia, PA
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
University of Pennsylvania - Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated:  12/14/2017
Atlantic Gastroenterology Associates
mi
from
Egg Harbor Township, NJ
A Trial of Rosiglitazone for Ulcerative Colitis
A Randomized, Placebo-controlled Trial of Rosiglitazone for Treatment of Ulcerative Colitis
Status: Enrolling
Updated: 12/14/2017
Atlantic Gastroenterology Associates
mi
from
Egg Harbor Township, NJ
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Memorial Hospital of South Bend
mi
from
South Bend, IN
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated:  12/28/2017
Kings County Hospital Center
mi
from
Brooklyn, NY
IBP-9414 for the Prevention of Necrotizing Enterocolitis
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Status: Enrolling
Updated: 12/28/2017
Kings County Hospital Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials